-
Stanford Medicine study discovers what’s behind heart cell damage from chemotherapy
Researchers used a new screening technique to identify genes involved in heart cell damage during a common chemotherapy treatment. They also found a drug that may be able to prevent it.
-
FDA approves Stanford Medicine-developed drug that treats rare heart disease
New drug treats a rare heart disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.
News & Research
-
Albertelli now heads comparative medicine
Animal model expert and genetics researcher Megan Albertelli, DVM, PhD, now heads Stanford School of Medicine department that contrasts human and animal health.
-
Lymphoma therapy shows promise
In an early Stanford Medicine study, CAR-T cell therapy helps some with intractable lymphoma, but those who relapse have few options. Modifying the therapy’s molecular target improved response.
-
Predicting spinal cord recovery
Making a prognosis for spinal cord injury has been a guessing game, but a neuroimaging study by Stanford Medicine scientists and collaborators finds answers hiding in plain sight.
-
New compound supercharges naloxone
In a Stanford Medicine-led study, researchers combed through billions of compounds to find one that could enhance naloxone’s ability to fend off more potent opioids, with promising results in mice.
-
Tapping the inner muse
“Honor the wisdom, the universe of knowledge that lies untouched within you,” the physician and novelist told the newly minted MDs, PhDs and master’s degree holders.
-
Wu Liu dies at 51
Wu Liu, known for his sense of humor and optimism, was a national expert in radiation treatments for eye cancer.
-
Gene therapy for neurologic disease
Experts at Stanford Medicine Children’s Health helped conduct clinical trials for the new therapy, which gives kids with X-linked adrenoleukodystrophy, or ALD, a functioning copy of the abnormal gene.
-
Customizable AI tool aids pathologists
The artificial intelligence technology can be trained by pathologists, giving them personalized assistance in identifying cells that might indicate diseases such as cancer or endometritis.
-
‘Optimism is simply the better choice’
At the graduation ceremony, Minor encouraged the Class of 2024 to choose optimism in their careers: “Create the best out of any situation and be the light that leads others.”…
-
Graduation emphasizes personal growth
Speakers at the ceremony that awarded PhD, MD and master’s degrees encourage students to adopt optimism, listen to their muse and dance to their own beat.
Other Stanford
Medicine News
- September 17, 2024 – Stanford Report
Kit makes CRISPR education affordable and accessible
An inexpensive kit developed by Stanford undergraduates brings hands-on lessons in the gene-editing technology to high school classrooms.